
0:00
NaN:NaN:NaN
David Dodd/GeoVax GeoVax Labs is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world’s most threatening infectious diseases. The company’s lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax’s […]
More episodes from "Simon Says"



Don't miss an episode of “Simon Says” and subscribe to it in the GetPodcast app.








